If you are planning to attend the 23rd International Congress of The Transplantation Society in Vancouver, be sure to check out our poster:
Andrew Breite, et al. Purification and Characterization of Clostridium histolyticum Neutral Protease used for Human Islet Isolation (number P46.49)
Since all posters will be available throughout the meeting, please make an appointment with Drew to discuss his results by contacting him at the meeting or at abreite@vitacyte.com
This R&D work reflects VitaCyte’s ongoing commitment to provide products that keep abreast of new developments in islet isolation. The R&D was stimulated by research at the University of Minnesota (UMN) that showed the combination of VitaCyte’s CIzyme Collagenase HA and Serva’s NB neutral protease gave higher human islet yields than other combinations of enzymes1. The UMN group will update their results on the use of this new enzyme mixture in an oral presentation by A.N. Balamurugan, et al titled “A New Enzyme Mixture to Consistently Achieve High Human Islet Yield and Improved Allogenic and Autograft Islet Transplantation Outcome” (M021.03). He will be summarizing the use of this new enzyme mixture to increase the success rates of islet isolation from pancreata obtained from patients with chronic pancreatitis and from organ donors for use in auto and allo islet transplantation, respectively. For more details, see http://abstracts.webges.com/myitinerary/?congress=tts2010 to review Balamurugan’s or Breite’s abstract.
For more information on VitaCyte’s products, please visit our website at www.vitacyte.com
1. Balamurugan AN, Loganathan G, Anazawa T, Wilhelm JJ , Yuasa T, Radosevich DM, Papas KK, Sutherland DER., McCarthy RC, and Hering BJ. 2009. Improved method of human islet isolation for clinical transplantation using combination of Clostridium
histolyticum neutral protease (Serva) and high proportion of intact C1 collagenase (VitaCyte). Xenotransplant 16: 545.